Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

We prospectively investigated the efficacy and safety of combining weekly vinorelbine (VNB) with weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) and leucovorin (LV) in the treatment of patients with advanced breast cancer (ABC). Vinorelbine 25 mg m(−2) 30-min intravenous infusion, and high-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, K H, Lu, Y S, Hsu, C H, Lin, J F, Chao, H J, Huang, T C, Chung, C Y, Chang, C S, Yang, C H, Cheng, A L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361932/
https://www.ncbi.nlm.nih.gov/pubmed/15770209
http://dx.doi.org/10.1038/sj.bjc.6602469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361932/
https://www.ncbi.nlm.nih.gov/pubmed/15770209
http://dx.doi.org/10.1038/sj.bjc.6602469

Ejemplares similares